Epigenetic pathways and glioblastoma treatment: insights from signaling cascades

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Glioblastoma (GBM) remains largely untreatable with current therapies.
• Identifying novel therapeutic targets is crucial for advancing GBM treatment.
• Epigenetic modulators are increasingly recognized as potential drug targets in cancer.

Purpose of the Study:

• To review recent studies linking epigenetic regulators and signaling pathways in GBM.
• To explore systems and big data approaches for personalized GBM therapies.
• To identify potential drug combinations for GBM and other cancers.

Main Methods:

• Literature review of epigenetic regulators in GBM.
• Analysis of interactions between epigenetic modulators and GBM signaling pathways (Notch, Hedgehog, WNT).
• Review of systems biology and big data strategies for therapeutic target identification.

Main Results:

• Epigenetic regulators influence GBM cell and stem-like cell proliferation.
• Interactions between epigenetic and signaling pathways are key in GBM.
• Systems and big data approaches can facilitate patient-specific therapy identification.

Conclusions:

• Epigenetic modulators represent promising therapeutic targets for glioblastoma.
• Targeting the interplay between epigenetic and signaling pathways may yield effective treatments.
• Integrated data approaches can accelerate the discovery of novel drug combinations for GBM.